This article has multiple issues. Please help improve it or discuss these issues on the talk page . (Learn how and when to remove these template messages)
|
Abbreviation | IBT |
---|---|
Purpose | biotechnology |
Location | |
Key people | Dr. Cheryl Lyn Walker (Current Director) Dr. Robert Schwartz( Director, 2006-2009) Dr. Richard Finnell( Director, 2001-2005) Dr. Fuller W. Bazer( Director, 1994-2001) Dr. Robert D. Wells( Director, 1990-1994) Mr. David Eller Dr. Richard Wainerdi Dr. Charles Arntzen Ray Bowen Dr. David Low Dr. David Carlson |
The Texas A&M Institute of Biosciences and Technology (IBT), a component of Texas A&M Health, and The Texas A&M University System, is located in the world's largest medical center, the Texas Medical Center, [1] in Houston, Texas. The institute provides a bridge between Texas A&M University System scientists and other institutions' researchers working in the Texas Medical Center and the biomedical and biotechnology research community in Houston. It emphasizes collaboration between member scientists and others working in all the fields of the biosciences and biotechnology. IBT encourages its scientists to transfer discoveries made in their laboratories to the clinic and marketplace.
The IBT was first established as part of the Texas A&M University System with the broad goal to expand biotechnology in the system. [2] Plans for an institutional campus in Houston came to fruition in 1986 under Mr. David Eller (Chairman of the Texas A&M University System Board of Regents) and Dr. Richard Wainerdi (Chairman and CEO of the Texas Medical Center). Dr. Eugene G. Sander, head of the Department of Biochemistry and Biophysics in the Texas A&M College of Agriculture and Life Sciences (COALS) was named first director of the institute. The Robert A. Welch Foundation [3] endowed a $1 million Robert A. Welch Chair in 1990.
In 1988 the institute administration was moved from the Texas A&M University System to the Texas A&M University under the leadership of Dr. Charles Arntzen, Vice Chancellor of Agriculture and Dean of the College of Life Sciences and Agriculture (COALS). Arntzen secured a grant from the United States Department of Agriculture for $12.5 million and other private donations including one from Texas oilman Albert B. Alkek to build the Albert B. Alkek Institute of Biosciences and Technology Building in the Texas Medical Center at a cost of $21.5 million. The 11-story building stands on the former site of the historic Shamrock Hotel. Under Arntzen's leadership, Centers for Animal Genetics, Advanced Invertebrate Molecular Sciences and Biotechnology Policy and Ethics were established and funding secured for additional endowed chairs from the Allen, John S. Dunn, and Neva and Wesley West (see Wesley West) Foundations. In 1990, he recruited Dr. Robert D. Wells into the Welch Chair as Chairman of the Department of Biochemistry and Biophysics (COALS) and Director of the IBT. Under Wells directorship (1990–1994), Centers for Genome Research, Macromolecular Design, Extracellular Matrix Biology, Crop Biotechnology, Animal Biotechnology, Genome Informatics and Cancer Biology were established.[ citation needed ]
Dr. Fuller W. Bazer was Director from 1994 to 2001. Under the Bazer administration by agreement between the Texas A&M University President Ray Bowen and The University of Texas Health Science Center at Houston President Dr. David Low, the University of Texas' Institute of Molecular Medicine for Prevention of Human Disease (Hans Muller-Eberhard, Director) [4] was established on two floors of the IBT building. During this period similar cooperative efforts between Texas A&M University and The University of Texas Health Science Center at Houston resulted in acceptance of IBT Texas A&M faculty into the UT Graduate School of Biomedical Sciences. The building became a hub for the Texas GigaPop and similar high speed, broad bandwidth internet activities of the Texas A&M University's Academy for Advanced Telecommunications and Distance Learning. In 1997 the IBT became a college level unit of the newly established Texas A&M Health Science Center.[ citation needed ]
Dr. Richard Finnell served as director 2001-2005 under whose leadership the Texas Institute for Genomic Medicine (TIGM) was established. Dr. Robert Schwartz served as director for 2006–2009. In 2007 a self-study called for a strategic plan in which the IBT would be the founding basic research element of a broader Texas A&M Health Science Center Houston Campus representing all components of the Health Science Center in Houston. Dr. David Carlson, the Texas A&M Health Science Center Vice President of Research and Graduate Studies served as the interim IBT Director 2009–2011. In 2011 Dr. Cheryl Lyn Walker was appointed as the current Director of IBT.[ citation needed ]
Under its college level status within Texas A&M Health, the IBT consists of thematic Centers (departments) led by a Center Director and tenured and tenure-track faculty, research track faculty and associate and adjunct faculty.
The approximately $10 million operating budget of the IBT consists of about 30% state funds, 50% federal grants and 20% private sources. Current Centers include Cancer and Stem Cell Biology (formerly Cancer Biology and Nutrition), Epigenetics and Disease Prevention, Environmental and Genetic Medicine, Infectious and Inflammatory Diseases (formerly Extracellular matrix Biology) and Translational Cancer Research.
The IBT Graduate Program [5] consists of students from the Texas A&M Health Science Center Graduate School of Biomedical Sciences, other Texas A&M System programs, The University of Texas Health Science Center at Houston Graduate School of Biomedical Sciences and other programs in Texas Medical Center institutions in which faculty have joint graduate faculty appointments. Students do research in IBT laboratories while taking formal classroom instruction at other Texas Medical Center institutions.
In addition to the IBT, the Texas A&M Health Science Center Alkek Building hosts the Houston division of the Texas Institute for Genomic Medicine, [6] representatives of the Texas A&M Health Science Center College of Medicine, School of Rural Public Health and Baylor College of Dentistry. Two floors of the building are dedicated to a partnership with the Department of Medicine of The University of Texas M. D. Anderson Cancer Center.
The University of Texas Medical Branch (UTMB) is a public academic health science center in Galveston, Texas, United States. It is part of the University of Texas System. UTMB includes the oldest medical school in Texas, and has about 11,000 employees. In February 2019, it received an endowment of $560 million.
The University of Texas Southwestern Medical Center is a public academic health science center in Dallas, Texas. With approximately 23,000 employees, more than 3,000 full-time faculty, and nearly 4 million outpatient visits per year, UT Southwestern is the largest medical school in the University of Texas System and state of Texas. The institution has been consistently ranked among the top medical schools in the United States.
The University of Texas MD Anderson Cancer Center is a comprehensive cancer center in Houston, Texas. It is the largest cancer center in the U.S. and one of the original three comprehensive cancer centers in the country. It is both a degree-granting academic institution and a cancer treatment and research center located at the Texas Medical Center in Houston. It is affiliated with The University of Texas Health Science Center at Houston. According to Newsweek, MD Anderson Cancer Center is considered the best hospital in the world for oncology and related cancer treatment.
The University of Texas Health Science Center at Houston (UTHealth) is a public academic health science center in Houston, Texas, United States. It was created in 1972 by The University of Texas System Board of Regents. It is located in the Texas Medical Center, the largest medical center in the world. It is composed of six schools: McGovern Medical School, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, UTHealth School of Dentistry, Cizik School of Nursing, UTHealth School of Biomedical Informatics and UTHealth School of Public Health.
The University of Texas Health Science Center at San Antonio is a public academic health science center in San Antonio, Texas. It is part of the University of Texas System.
Texas A&M Health, also known as Texas A&M University Health, and Texas A&M University Health Science Center, is the medical education component of Texas A&M University, and offers health professions research, education and patient care in dentistry, medicine, nursing, biomedical sciences, public health, and pharmacy on its several campuses. One of the fastest-growing academic health centers in the nation, Texas A&M Health encompasses six schools and numerous centers and institutes. It was established in 1999 as an independent institution of the Texas A&M University System and received accreditation in December 2002 from the Southern Association of Colleges and Schools to award baccalaureate, master's, doctoral and professional degrees. The institution and its colleges merged with Texas A&M University on July 12, 2013.
The Kaohsiung Medical University is a private medical school located in Sanmin District, Kaohsiung, Taiwan.
Charles Thomas Caskey, also known as C. Thomas Caskey, was an American internist who has been a medical Geneticist and biomedical researcher and entrepreneur. He was a Professor of Molecular and Human Genetics at Baylor College of Medicine, and served as editor of the Annual Review of Medicine from 2001 to 2019. He was a member of the editorial boards of the Proceedings of the National Academy of Sciences, Science, the Encyclopedia of Molecular Medicine and numerous other medical and scientific journals.
Georgetown University Medical Center is a biomedical research and educational organization that responsible for over 80% of Georgetown University's sponsored research funding and is led by Edward B. Healton, MD, the Executive Vice President for Health Sciences and Executive Dean of the School of Medicine.
Hashem B. El-Serag is a Palestinian-American physician and medical researcher best known for his research in liver cancer, hepatocellular carcinoma (HCC) and the hepatitis C virus. He serves as the Margaret M. and Albert B. Alkek Chairman of the Department of Medicine at Baylor College of Medicine as well as the Director of the Texas Medical Center Digestive Disease Center. El-Serag previously served as president of the American Gastroenterological Association and Editor-in-Chief of Clinical Gastroenterology and Hepatology.
William R. "Bill" Brinkley, was an American cellular biologist and scientific advocate and served as a Professor and Dean of the Graduate School of Biomedical Sciences at Baylor College of Medicine. Brinkley was recognized particularly for contributing to discovery of the attachment of chromosomes to the mitotic spindle apparatus.
Christopher Carl Goodnow is an immunology researcher and the current executive director of the Garvan Institute of Medical Research. He holds the Bill and Patricia Ritchie Foundation Chair and is a Conjoint Professor in the faculty of medicine at UNSW Sydney. He holds dual Australian and US citizenship.
Paul Billings is an American doctor, lecturer, researcher, professor, and consultant on genetic information. His major research interests include the impact of genomic information and biotechnology on society, the integration of genomics and diagnostics in to health and medical care and individualized genomic medicine. Dr. Paul Billings is the author of more than 250 publications and books on genomic medicine, has spoken at numerous medical conferences, and appeared on talk shows such as The Oprah Show and 60 Minutes. He is currently the chief medical officer of Natera, chairman of Biological Dynamics, Inc. and Plumcare LLC, and CEO of Synergenz Bioscience, Inc.
Charles Joel Arntzen is a plant molecular biologist. His major contributions are in the field of "plant molecular biology and protein engineering, as well as the utilization of plant biotechnology for enhancement of food quality and value, for expression of pharmacological products in transgenic plants, and for overcoming health and agricultural constraints in the developing world."
The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences (UT-GSBS), formerly The University of Texas Graduate School of Biomedical Sciences at Houston, is a joint venture of the University of Texas Health Science Center at Houston (UTHealth) and the University of Texas MD Anderson Cancer Center. It offers Ph.D. and M.S. degrees in many areas of study, and a M.D./Ph.D. program in collaboration with The University of Texas Medical School at Houston, and it is fully accredited by the Southern Association of Colleges and Schools through both its parent institutions, UTHealth and MD Anderson. It is located in the heart of the Texas Medical Center.
The BioScience Research Collaborative (BRC) is a collaborative life science research building in the Texas Medical Center in Houston, Texas. It is similar in concept to the Clark Center/BioX at Stanford University and the Broad Institute at MIT, among other collaborative centers. After Rice University President David Leebron announced his "Vision for the Second Century," including plans to increase research funding, build up existing programs, and increase collaboration between Rice and other entities, the construction of the BRC went forward with the intention of fostering collaboration with the neighboring Texas Medical Center. The BRC was built by Rice University, and officially opened in April 2010. A unique characteristic of the BRC as compared to other academic research institutes is the shared research space by faculty from Rice University and groups from neighboring Texas Medical Center institutions. Collaborative research provides an advantage over traditional research in that multiple professors, or principal investigators, and their laboratory groups work together on different aspects of the same problem which usually results in finding a solution in a shorter amount of time.,
Barnet Mortimer Levy was an American oral pathologist and professor at universities in the United States and Mexico. Levy worked to integrate basic science research into dentistry, believing that oral health should not be separated from other aspects of health. He co-authored an influential textbook, co-founded a research institute in Texas, and served in national leadership roles, including the presidency of the International Association for Dental Research and the American Academy of Oral & Maxillofacial Pathology.
Cheryl Lyn Walker is an American molecular biologist.
Kenneth S. Ramos is an American physician-scientist.